Advanced Mtap Null Solid Tumors clinical trials

Explore recruiting advanced mtap null solid tumors clinical trials.

Also recruiting in Europe

Advanced Mtap Null Solid Tumors trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A phase 1/1b/2 study evaluating the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of AMG 193 alone and in combination with docetaxel in subjects with advanced MTAP-null solid tumors

Belgium, Germany, Austria, France

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

A Phase 1/2 Study Evaluating the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of AMG 193 in Combination With IDE397 in Subjects With Advanced MTAP-null Solid Tumors

Spain, Denmark

Phase I and Phase II (Integrated)- Other EU CTIS Study details

Advanced Mtap Null Solid Tumors trials by city

Advanced Mtap Null Solid Tumors in Toronto Advanced Mtap Null Solid Tumors in Vancouver Advanced Mtap Null Solid Tumors in Montreal Advanced Mtap Null Solid Tumors in Calgary Advanced Mtap Null Solid Tumors in Edmonton Advanced Mtap Null Solid Tumors in Ottawa Advanced Mtap Null Solid Tumors in Winnipeg Advanced Mtap Null Solid Tumors in Quebec City Advanced Mtap Null Solid Tumors in Hamilton Advanced Mtap Null Solid Tumors in Kitchener Advanced Mtap Null Solid Tumors in London Advanced Mtap Null Solid Tumors in Halifax Advanced Mtap Null Solid Tumors in New York Advanced Mtap Null Solid Tumors in Los Angeles Advanced Mtap Null Solid Tumors in Chicago Advanced Mtap Null Solid Tumors in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease